Software as treatments

Our Mission

Deliver safe and effective digital treatments to patients in need

We develop, validate, and commercialize software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments.

Developing Software
As Treatments

We are a regulated Software as a Medical Device (SaMD)-focused biotechnology company that develops our applications as medical treatments in accordance with all relevant FDA, ISO and IEC standards.

We develop prescription software applications as medical devices that work independently or in conjunction with pharmacotherapies to treat disease.
We clinically validate these applications through rigorous randomized, controlled trials to demonstrate safety and efficacy.
We seek FDA clearance for our apps as class II medical devices with independent therapeutic treatment claims or as adjuncts to existing therapy.
Physicians prescribe our apps and payers reimburse for them, while we generate and apply real world evidence to continuously personalize and improve the applications.


David B. Klein
Chief Executive Officer
Randall Stanicky
Chief Financial Officer
Han Chiu
Chief Technology Officer
Austin C. Speier
Chief Strategy Officer
Shaheen Lakhan, MD, PhD, FAAN
Chief Medical Officer
Richard DeNunzio
Senior Vice President, Commercial
Heather Knigin
Senior Vice President, People
Tarique Collins
Senior Vice President, Legal, Compliance & Privacy

In The News

Our Collaborators

Contact us

Email us

Our office

80 White Street
New York, NY 10013